Conversely, other medical societies such as the American Cancer Society (ACS) have recommended men aged ≥ 50 years with average risk and men aged ≥ 40 years with higher risk for prostate cancer to be screened by PSA annually since 1992 [11]. This evidence concerns the gene KLK3 and prostate cancer.